The FDA expands approval of Skyrizi (risankizumab-rzaa) for pediatric patients aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis.

Connected TV homes in India are rapidly increasing, reaching forty million in 2025. Advertiser interest has grown ...

The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...

From U.S. v. Virginia, decided yesterday by Judge Robert Payne (E.D. Va.); these conclusions played a role in the ...

RelabotulinumtoxinA is a liquid neuromodulator designed to deliver rapid clinical improvement in glabellar and lateral canthal lines.

The following is the full transcript of an interview with former CDC chief medical officer Dr. Debra Houry, a portion of which aired on "Face the Nation with Margaret Brennan" on July 5, 2026. This ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

We knew this was coming, Google Ads now allows you to upload your customer loyalty data, i.e. Customer Match data, via the ...

A sweeping slate of new California state laws is in effect July 1, introducing strict regulations across public education, ...

A multinational aerospace, defense, and security technology company has begun marketing an upgrade to its Automatic License Plate Reader (ALPR) system that records smart device identifiers — like ...

Notified body association Team-NB has suggested changes to the European Commission’s proposals for risk-adaptive surveillance ...

Usual care in combination with Project Life Force lowers the risk for actual suicide attempts and improves coping skills in veterans with high risk.